116 related articles for article (PubMed ID: 1613735)
1. Proteinases in rheumatoid arthritis.
Murphy G; Hembry RM
J Rheumatol Suppl; 1992 Jan; 32():61-4. PubMed ID: 1613735
[TBL] [Abstract][Full Text] [Related]
2. [Role of matrix metalloproteinases in the joint destruction].
Okada Y
Nihon Seikeigeka Gakkai Zasshi; 1994 Sep; 68(9):808-17. PubMed ID: 7963934
[No Abstract] [Full Text] [Related]
3. [Proteinases in pathogenesis of rheumatoid arthritis].
Mochizuki S; Yatabe T; Okada Y
Nihon Rinsho; 2005 Jan; 63 Suppl 1():208-14. PubMed ID: 15799347
[No Abstract] [Full Text] [Related]
4. Role of metalloproteinases in human osteoarthritis.
Woessner JF; Gunja-Smith Z
J Rheumatol Suppl; 1991 Feb; 27():99-101. PubMed ID: 1851233
[TBL] [Abstract][Full Text] [Related]
5. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
[TBL] [Abstract][Full Text] [Related]
6. Effects of lipid peroxide on production of matrix metalloproteinase 1 (tissue collagenase) and 3 (stromelysin) and tissue inhibitor metalloproteinase 1 by human rheumatoid synovial fibroblasts.
Hiraoka K; Sasaguri Y; Komiya S; Zenmyo M; Inoue A; Morimatsu M
Exp Mol Pathol; 1993 Dec; 59(3):169-76. PubMed ID: 8137899
[TBL] [Abstract][Full Text] [Related]
7. The functional balance of metalloproteinases and inhibitors in tissue degradation: relevance to oral pathologies.
Reynolds JJ; Meikle MC
J R Coll Surg Edinb; 1997 Jun; 42(3):154-60. PubMed ID: 9195805
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in loose artificial hip joints.
Takagi M; Santavirta S; Ida H; Ishii M; Mandelin J; Konttinen YT
Clin Orthop Relat Res; 1998 Jul; (352):35-45. PubMed ID: 9678031
[TBL] [Abstract][Full Text] [Related]
9. Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis.
Martel-Pelletier J; McCollum R; Fujimoto N; Obata K; Cloutier JM; Pelletier JP
Lab Invest; 1994 Jun; 70(6):807-15. PubMed ID: 8015285
[TBL] [Abstract][Full Text] [Related]
10. The regulation of connective tissue metalloproteinases by natural inhibitors.
Murphy G
Agents Actions Suppl; 1991; 35():69-76. PubMed ID: 1781423
[TBL] [Abstract][Full Text] [Related]
11. ADAMTS proteinases: a multi-domain, multi-functional family with roles in extracellular matrix turnover and arthritis.
Jones GC; Riley GP
Arthritis Res Ther; 2005; 7(4):160-9. PubMed ID: 15987500
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinases and their inhibitors in connective tissue remodeling.
Woessner JF
FASEB J; 1991 May; 5(8):2145-54. PubMed ID: 1850705
[TBL] [Abstract][Full Text] [Related]
13. Neutral proteinases of human mononuclear phagocytes. Cellular differentiation markedly alters cell phenotype for serine proteinases, metalloproteinases, and tissue inhibitor of metalloproteinases.
Campbell EJ; Cury JD; Shapiro SD; Goldberg GI; Welgus HG
J Immunol; 1991 Feb; 146(4):1286-93. PubMed ID: 1991967
[TBL] [Abstract][Full Text] [Related]
14. [Expression of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs) in joint tissues of rapidly destructive coxarthropathy (RDC), analyzed by immunohistochemical study].
Matsumoto F; Uzuki M; Kaneko C; Rikimaru A; Kokubun S; Sawai T
Ryumachi; 1997 Oct; 37(5):688-95. PubMed ID: 9396371
[TBL] [Abstract][Full Text] [Related]
15. Biochemical mechanisms of articular destruction.
Mainardi CL
Rheum Dis Clin North Am; 1987 Aug; 13(2):215-33. PubMed ID: 3321209
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinases and their inhibitors.
Murphy G
Acta Orthop Scand Suppl; 1995 Oct; 266():55-60. PubMed ID: 8553862
[No Abstract] [Full Text] [Related]
17. Matrix metalloproteinases and tissue inhibitor of metalloproteinases: a review of their role in tumorigenesis and tissue invasion.
Khokha R; Denhardt DT
Invasion Metastasis; 1989; 9(6):391-405. PubMed ID: 2689386
[TBL] [Abstract][Full Text] [Related]
18. Suppressive effects of the new antirheumatic drug KE-298 on TNF alpha-induced production of matrix metalloproteinases but not of tissue inhibitor-1 of metalloproteinases in human rheumatoid synoviocytes.
Takahashi S; Inoue T; Higaki M; Mizushima Y
Drugs Exp Clin Res; 1998; 24(2):67-71. PubMed ID: 9675546
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinases in the formation of human synovial joint cavities.
Edwards JC; Wilkinson LS; Soothill P; Hembry RM; Murphy G; Reynolds JJ
J Anat; 1996 Apr; 188 ( Pt 2)(Pt 2):355-60. PubMed ID: 8621334
[TBL] [Abstract][Full Text] [Related]
20. Expression of matrix metalloproteinases and inhibitor by human retinal pigment epithelium.
Alexander JP; Bradley JM; Gabourel JD; Acott TS
Invest Ophthalmol Vis Sci; 1990 Dec; 31(12):2520-8. PubMed ID: 2176183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
